CBFβ is critical for AML1-ETO and TEL-AML1 activity
Open Access
- 26 March 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (13) , 3070-3079
Abstract
AML1-ETO and TEL-AML1 are chimeric proteins resulting from the t(8;21)(q22;q22) in acute myeloid leukemia, and the t(12;21)(p13;q22) in pre-B-cell leukemia, respectively. The Runt domain of AML1 in both proteins mediates DNA binding and heterodimerization with the core binding factor β (CBFβ) subunit. To determine whether CBFβ is required for AML1-ETO and TEL-AML1 activity, we introduced amino acid substitutions into the Runt domain that disrupt heterodimerization with CBFβ but not DNA binding. We show that CBFβ contributes to AML1-ETO's inhibition of granulocyte differentiation, is essential for its ability to enhance the clonogenic potential of primary mouse bone marrow cells, and is indispensable for its cooperativity with the activated receptor tyrosine kinase TEL-PDGFβR in generating acute myeloid leukemia in mice. Similarly, CBFβ is essential for TEL-AML1's ability to promote self-renewal of B cell precursors in vitro. These studies validate the Runt domain/CBFβ interaction as a therapeutic target in core binding factor leukemias.Keywords
This publication has 98 references indexed in Scilit:
- RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesisBlood, 2009
- AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its TargetsPLOS Genetics, 2008
- Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesisProceedings of the National Academy of Sciences, 2008
- Structural Basis for Recognition of SMRT/N-CoR by the MYND Domain and Its Contribution to AML1/ETO's ActivityCancer Cell, 2007
- Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant‐negative, or hypomorphic allelesThe EMBO Journal, 2007
- A Mutation in the S-switch Region of the Runt Domain Alters the Dynamics of an Allosteric Network Responsible for CBFβ RegulationJournal of Molecular Biology, 2006
- The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domainProceedings of the National Academy of Sciences, 2006
- TEL/AML1 shows dominant-negative effects over TEL as well as AML1Biochemical and Biophysical Research Communications, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- The ETO (MTG8) gene familyGene, 2003